35.14
-1.84 (-4.98%)
-1.84 (-4.98%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 140,567 |
|
|||||
| News | - | ||||||
| Day High | 36.89 | Low High |
|||||
| Day Low | 34.91 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| iTeos Therapeutics Inc | ITOS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -1.84 | -4.98% | 35.14 | 16:00:25 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 36.26 | 34.91 | 36.89 | 35.14 | 36.98 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,597 | 140,567 | $ 35.75 | $ 5,024,885 | - | 17.43 - 47.61 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:01:36 | formt | 120 | $ 35.14 | USD |
Period:
Draw Mode:
iTeos Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.24B | 35.27M | 20.18M | $ - | $ - | -0.49 | 29.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -1.90M | 0.50% |
iTeos Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ITOS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 36.81 | 38.77 | 34.82 | 37.27 | 315,262 | -1.67 | -4.54% |
| 1 Month | 27.54 | 38.77 | 26.21 | 32.79 | 270,665 | 7.60 | 27.6% |
| 3 Months | 29.33 | 38.77 | 25.41 | 29.96 | 189,477 | 5.81 | 19.81% |
| 6 Months | 20.80 | 38.77 | 17.43 | 25.97 | 329,752 | 14.34 | 68.94% |
| 1 Year | 29.96 | 47.61 | 17.43 | 28.28 | 284,046 | 5.18 | 17.29% |
| 3 Years | 19.70 | 47.61 | 17.43 | 27.84 | 255,433 | 15.44 | 78.38% |
| 5 Years | 19.70 | 47.61 | 17.43 | 27.84 | 255,433 | 15.44 | 78.38% |
iTeos Therapeutics Description
| ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody. |
